Pfizer Schedules Board Meeting to Consider Unaudited Financial Results for Quarter Ended June 30, 2026
Pfizer Ltd has scheduled a meeting of its Board of Directors to review and approve the unaudited financial results for the quarter ended June 30, 2026. The meeting is set to be held on Tuesday, July 28, 2026.The board meeting is intended to consider, approve, and formally record the unaudited financial results of the company corresponding to the period ending June 30, 2026.
In addition to the board review, Pfizer also provided an update regarding the trading window for dealing in its shares. The trading window remains closed from Tuesday, June 30, 2026 (close of business) until a duration of 48 hours following the public release of the financial results on July 28, 2026.
PFIZER Stock Price Movement
Today, shares of Pfizer Limited edged higher to settle at ₹4577.9, registering a gain of 0.16%. The stock traded within an intraday range of ₹4545 and ₹4590 on a volume of 9,994 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.